A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis

NCT07260669 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: Vipoglanstat
DRUG: Placebo

Sponsor

Gesynta Pharma AB